1-(5-isoquinolinesulfonyl)-2-methylpiperazine has been researched along with Complications of Diabetes Mellitus in 2 studies
1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine: A specific protein kinase C inhibitor, which inhibits superoxide release from human neutrophils (PMN) stimulated with phorbol myristate acetate or synthetic diacylglycerol.
1-(5-isoquinolinesulfonyl)-2-methylpiperazine : A member of the class of N-sulfonylpiperazines that is 2-methylpiperazine substituted at position 1 by a 5-isoquinolinesulfonyl group.
Excerpt | Relevance | Reference |
---|---|---|
"Atorvastatin has been employed in the present study as standard agent to improve vascular endothelial dysfunction." | 1.33 | Involvement of Rho-kinase in experimental vascular endothelial dysfunction. ( Shah, DI; Singh, M, 2006) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Mishra, RK | 1 |
Alokam, R | 1 |
Sriram, D | 1 |
Yogeeswari, P | 1 |
Shah, DI | 1 |
Singh, M | 1 |
1 review available for 1-(5-isoquinolinesulfonyl)-2-methylpiperazine and Complications of Diabetes Mellitus
Article | Year |
---|---|
Potential role of Rho kinase inhibitors in combating diabetes-related complications including diabetic neuropathy--a review.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Amides; Animals; Cardiomyopathies; Diabetes Complicat | 2013 |
1 other study available for 1-(5-isoquinolinesulfonyl)-2-methylpiperazine and Complications of Diabetes Mellitus
Article | Year |
---|---|
Involvement of Rho-kinase in experimental vascular endothelial dysfunction.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Acetylcholine; Animals; Antibiotics, Antineoplastic; | 2006 |